-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on Bristol-Myers Squibb

Benzinga·07/31/2026 13:01:34
语音播报
Truist Securities analyst Robyn Karnauskas reiterates Bristol-Myers Squibb (NYSE:BMY) with a Buy.